Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?

Cholesteryl ester transfer protein (CETP) inhibitors significantly increase serum high-density lipoprotein cholesterol (HDL) cholesterol levels and decrease low-density lipoprotein cholesterol (LDL) cholesterol concentration. However, three drugs of this class failed to show a decrease of cardiovasc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diseases
Main Authors: Filippatos, Theodosios D., Kei, Anastazia, Elisaf, Moses S.
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2017
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750532/
https://ncbi.nlm.nih.gov/pubmed/28961179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases5040021
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker